VERVE THERAPEUTICS INC. - COMMON STOCK

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

29 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results

05 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 نوفمبر 2024 16:26:49 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 أكتوبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 سبتمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results

08 أغسطس 2024 07:00:01 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 أغسطس 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 يوليو 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors

28 يونيو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

31 مايو 2024 16:01:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Leadership Update

31 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics to Participate in Upcoming Investor Conferences

30 مايو 2024 16:01:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results

08 مايو 2024 07:00:01 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102

07 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 مايو 2024 16:01:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Updates on its PCSK9 Program

02 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

28 مارس 2024 16:51:34 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 مارس 2024 16:01:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results

27 فبراير 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01 فبراير 2024 06:30:00 بحسب Nasdaq GlobeNewswire